Reimbursement and practice policies among providers of buprenorphine- naloxone treatment

Substance Abuse

Volumn 34, Issue 2, 2013, Pages 105-107

  Wisniewski, Angela M ^a   Dlugosz, Michael R ^a   Blondell, Richard D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Buprenorphine; opioid related disorders; physician practice patterns

Indexed keywords

BUPRENORPHINE; NALOXONE;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PHYSICIAN; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; PSYCHOLOGY; REIMBURSEMENT; ARTICLE; OPIATE ADDICTION; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; BUPRENORPHINE; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; NALOXONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PHYSICIANS; PROFESSIONAL PRACTICE; REIMBURSEMENT MECHANISMS;

EID: 84876350307     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2012.677753     Document Type: Article

References (12)

1. Ponizovsky AM, Margolis A, Heled L, Rosca P, Radomislensky I, Grinshpoon A. Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance. Subst Use Misuse. 2010;45: 288-313.
2. Parran TV, Adelman CA, Merkin B, et al. Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy. Drug Alcohol Depend. 2010;106:56-60.
3. Monte AA, Mandell T,Wilford BB, Tennyson J, Boyer EW. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. J Addict Dis. 2009;28:226-231.
4. Schuman-Olivier Z, Albanese M, Nelson SE, et al. Self-treatment: illicit buprenorphine use by opioid dependent treatment seekers. J Subst Abuse Treat. 2010;39:41-50.
5. Center for Substance Abuse Treatment. ClinicalGuidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. Rockville, MD: Substance Abuse andMental Health Services Administration; 2004. DHHS Publication No. (SMA) 04-3939.
6. Horgan CM, Reif S, Hodgkin D, Garnick DW, Merrick EL. Availability of addiction medications in private health plans. J Subst Abuse Treat. 2008;34:147-156.
7. Substance Abuse and Mental Health Services Administration. Buprenorphine physician and treatment program locator. Available at: http://buprenorphine. samhsa.gov/bwns locator/. Accessed April 26, 2011.
8. Reckitt Benckiser Pharmaceuticals. Here to Help Program. Available at: http://www.heretohelpprogram.com/. Accessed April 27, 2011.
9. Magura S, Lee SJ, Salsitz EA, et al. Outcomes of buprenorphine maintenance in office-based practices. J Addict Dis. 2007;26: 13-23.
10. Colameco S, Armando J, Trotz C. Opiate dependence treatment with buprenorphine: one year's experience in a Family Practice residency setting. J Addict Dis. 2005;24:25-32.
11. Walley AY, Alperen JK, Cheng DM, et al. Office-based management of opioid dependence with buprenorphine: clinical practice and barriers. J Gen Intern Med. 2008;23:1393-1398.
12. Thomas CP, Reif S, Haq S, Wallack SS, Hoyt A, Ritter GA. Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. Psychiatr Serv. 2008;59: 909-916.